Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-05

Clinical Trial Update: PH94B in the Treatment of Adjustment Disorder With Anxiety [Phase 2]

View source ↗

Summary

Phase 2 trial of PH94B for adjustment disorder with anxious mood has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PH94B

Snippet

Sponsor: VistaGen Therapeutics, Inc. | Conditions: Adjustment Disorder With Anxious Mood | Phase 2 | Status: COMPLETED | Results posted: 2026-02-05